Epigenetic Cancer Therapy

Serie & gerelateerd

Meer over Translational

Honghui Zhou (Janssen Research & Development, LLC) || Frank-Peter Theil (UCB Biopharma)

ADME and Translational Pharmacokinetics / Pharmacodynamics of Therapeutic Proteins: Applications in Drug Discovery and Development

€ 155,55

Louise C Kenny (University of Cork and Director, The Irish Centre for Fetal and Neonatal Translational Research (INFANT)) || Jenny E. Myers (NIHR Clinician Scientist & Honorary Consultant in Obstetrics, Maternal & Fetal Health Research Centre, University of Manchester, UK)

Obstetrics by Ten Teachers

€ 35,76

John E. Hall, PhD (Arther C. Guyton Professor and Chair Department of Physiology and Biophysics Director, Mississippi Center for Obesity Research Director, Cardiorenal and Metabolic Diseases Research Center University of Mississippi Medical Center Jackson, Mississippi, USA) || Michael E. Hall

Guyton and Hall Textbook of Medical Physiology

€ 124,20

Louise C Kenny (University of Cork and Director, The Irish Centre for Fetal and Neonatal Translational Research (INFANT)) || Helen Bickerstaff (Senior Lecturer in Medical Education, King's College London; Honorary Consultant Obstetrician and Gynaecologist, Guy's and St Thomas' NHS Foundation Trust, London UK)

Gynaecology by Ten Teachers

€ 35,76

Reed E. Pyeritz (William Smilow Professor of Medicine and Professor of Genetics, Senior Fellow, Leonard Davis Institute of Health Economics, Perelman School of Medicine, University of Pennsylvania, Smilow Center for Translational Research, Philadelphia, PA, USA) || Bruce R. Korf (Chief Genomics Officer, UAB Medicine, Wayne H. and Sara Crews Finley Endowed Chair in Medical Genetics, University of Alabama at Birmingham, Birmingham, AL, USA) || Wayne W. Grody

Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Perinatal and Reproductive Genetics

€ 119,74

Gary S. Firestein (Distinguished Professor of Medicine, Senior Associate Vice Chancellor for Health Sciences, Director, Altman Clinical and Translational Research Institute, USA) || Ralph C. Budd (Professor of Medicine and Microbiology and Molecular Genetics, Director, Vermont Center for Immunology and Infectious Diseases, University of Vermont College of Medicine Distinguished University Professor, The University of Vermont College of Medicine, Burlington, Vermont) || Sherine E Gabriel, MD, MSc (Professor and Dean, Rutgers Robert Wood Johnson Medical School, CEO, Robert Wood Johnson Medical Group, Emeritus Professor, Mayo Clinic, New Brunswick, New Jersey) || Iain B. McInnes (Muirhead Professor of Medicine, Arthritis Research UK Professor of Rheumatology, Director of Institute of Infection,Immunity, and Inflammation, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, Scotland, United Kingdom) || James R. O'Dell (Bruce Professor and Vice Chairman of Internal Medicine, University of Nebraska Medical Center, Chief of Rheumatology, Department of Medicine, Omaha Veterans Affairs, Omaha, Nebraska, USA)

Firestein & Kelley's Textbook of Rheumatology, 2-Volume Set

€ 466,69

Abraham K. Abraham || Thor S. Eikhom || Ian F. Pryme

Protein Synthesis: Translational and Post-Translational Events

€ 142,68

Abraham K. Abraham || Thor S. Eikhom || Ian F. Pryme

Protein Synthesis: Translational and Post-Translational Events

€ 142,68

Vasili Hauryliuk

Translational GTPases

€ 69,85

Tomasz Tkaczyk

Translational Biophotonics

€ 164,80

Beschrijving

Over dit product

Epigenetic Cancer Therapy unites issues central to a translational audience actively seeking to understand the topic. It is ideal for cancer specialists, including oncologists and clinicians, but also provides valuable information for researchers, academics, students, governments, and decision-makers in the healthcare sector. The text covers the basic background of the epigenome, aberrant epigenetics, and its potential as a target for cancer therapy, and includes individual chapters on the state of epigenome knowledge in specific cancers (including lung, breast, prostate, liver). The book encompasses both large-scale intergovernmental initiatives as well as recent findings across cancer stem cells, rational drug design, clinical trials, and chemopreventative strategies. As a whole, the work articulates and raises the profile of epigenetics as a therapeutic option in the future management of cancer.